Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation

Anesthesia and Analgesia

Volumn 108, Issue 6, 2009, Pages 1922-1928

  Audibert, Gérard ^a   Steinmann, Gaëlle ^a   De Talancé, Nicole ^b   Laurens, Marie Hélène ^b   Dao, Pierre ^a   Baumann, Antoine ^a   Longrois, Dan ^a,c   Mertes, Paul Michel ^a,b  

^a Hôpital Central   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; ERYTHROCYTE TC 99M; RENIN; TROPONIN I; VASOPRESSIN; HORMONE; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD VOLUME; CARDIOVASCULAR AUTOREGULATION; CLINICAL ARTICLE; ELECTROCARDIOGRAM; ERYTHROCYTE VOLUME; FEMALE; FLUID BALANCE; FLUID THERAPY; HORMONAL REGULATION; HUMAN; HYPONATREMIA; MALE; NATRIURESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SODIUM BALANCE; SUBARACHNOID HEMORRHAGE; SYMPATHETIC TONE; TRANSTHORACIC ECHOCARDIOGRAPHY; VASOPRESSIN BLOOD LEVEL; ANESTHESIA; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; ELECTROLYTE BALANCE; ENDOCRINE GLAND; GLASGOW OUTCOME SCALE; HEMATOCRIT; HOMEOSTASIS; HYPOVOLEMIA; INTENSIVE CARE; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; NEUROSURGERY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

ADULT; ANESTHESIA; BLOOD VOLUME; ENDOCRINE GLANDS; FEMALE; GLASGOW OUTCOME SCALE; HEMATOCRIT; HOMEOSTASIS; HORMONES; HUMANS; HYPONATREMIA; HYPOVOLEMIA; INTENSIVE CARE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NATRIURESIS; NEUROSURGICAL PROCEDURES; RENIN-ANGIOTENSIN SYSTEM; SODIUM; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WATER-ELECTROLYTE BALANCE;

EID: 66349118314     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31819a85ae     Document Type: Article

References (44)

1. Naval NS, Stevens RD, Mirski MA, Bhardwaj A. Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med 2006;34:511-24
2. Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, Parra A, Connolly ES, Mayer SA. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006;34:617-23
3. Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 1990;27:106-8
4. Wijdicks EF, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol 1985;18:211-16
5. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006;354:387-96
6. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007;356:2064-72
7. Berendes E, Walter M, Cullen P, Prien T, Van Aken H, Horsthemke J, Schulte M, von Wild K, Scherer R. Secretion of brain natriuretic peptide in patients with aneurysmal subarach-noid haemorrhage. Lancet 1997;349:245-9
8. Espiner EA, Leikis R, Ferch RD, MacFarlane MR, Bonkowski JA, Frampton CM, Richards AM. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol (Oxf) 2002;56:629-35
9. Isotani E, Suzuki R, Tomita K, Hokari M, Monma S, Marumo F, Hirakawa K. Alterations in plasma concentrations of natriuretic peptides and antidiuretic hormone after subarachnoid hemorrhage. Stroke 1994;25:2198-203
10. Tomida M, Muraki M, Uemura K, Yamasaki K. Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke 1998;29:1584-7
11. Diringer M, Ladenson PW, Stern BJ, Schleimer J, Hanley DF. Plasma atrial natriuretic factor and subarachnoid hemorrhage. Stroke 1988;19:1119-24
12. Kurokawa Y, Uede T, Ishiguro M, Honda O, Honmou O, Kato T, Wanibuchi M. Pathogenesis of hyponatremia following sub-arachnoid hemorrhage due to ruptured cerebral aneurysm. Surg Neurol 1996;46:500-7
13. Wijdicks EF, Ropper AH, Hunnicutt EJ, Richardson GS, Nathanson JA. Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage. Stroke 1991;22:1519-24
14. Wijdicks EF, Schievink WI, Burnett JC. Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage. J Neurosurg 1997;87:275-80
15. Juul R, Edvinsson L, Ekman R, Frederiksen TA, Unsgard G, Gisvold SE. Atrial natriuretic peptide-LI following subarachnoid haemorrhage in man. Acta Neurochir (Wien) 1990;106:18-23
16. Sviri GE, Feinsod M, Soustiel JF. Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage. Clinical and TCD correlations. Stroke 2000;31:118-22
17. Drake CG. Report of the World Federation of Neurological Surgeons Committee on a universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988;68:985-86
18. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9
19. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-4
20. Solomon RA, Post KD, McMurtry JG III. Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery 1984;15:354-61
21. Rosen DS, Macdonald RL. Grading of subarachnoid hemorrhage: modification of the world World Federation of Neurosurgical Societies scale on the basis of data for a large series of patients. Neurosurgery 2004;54:566-75
22. Nelson PB, Seif SM, Maroon JC, Robinson AG. Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg 1981;55:938-41
23. Benedict CR, Loach AB. Sympathetic nervous system activity in patients with subarachnoid hemorrhage. Stroke 1978;9:237-44
24. Mason DT, Bartter FC. Autonomic regulation of blood volume. Anesthesiology 1968;29:681-92
25. Lee KH, Lukovits T, Friedman JA. Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care 2006;4:68-76
26. Singh S, Bohn D, Carlotti AP, Cusimano M, Rutka JT, Halperin ML. Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit Care Med 2002;30:2575-9
27. Findling JW, Waters VO, Raff H. The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab 1987;64:592-5
28. du Cheyron D, Lesage A, Daubin C, Ramakers M, Charbonneau P. Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure. Intensive Care Med 2003;29:1703-9
29. Carey RM, Thorner MO, Ortt EM. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. J Clin Invest 1979;63:727-35
30. de Jong FH, Mallios C, Jansen C, Scheck PA, Lamberts SW. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J Clin Endocrinol Metab 1984;59:1143-7
31. Fiad TM, Cunningham SK, Hayes FJ, McKenna TJ. Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis. J Clin Endocrinol Metab 1997;82:457-60
32. Iimura O, Shimamoto K. Efficacy and mode of action of manidip-ine: a new calcium antagonist. Am Heart J 1993;125:635-41
33. Shamiss A, Peleg E, Rosenthal T, Ezra D. The role of atrial natriuretic peptide in the diuretic effect of Ca2+ entry blockers. Eur J Pharmacol 1993;233:113-17
34. Braley LM, Adler GK, Mortensen RM, Conlin PR, Chen R, Hallahan J, Menachery AI, Williams GH. Dose effect of adrenocorticotropin on aldosterone and cortisol biosynthesis in cultured bovine adrenal glomerulosa cells: in vitro correlate of hyperreninemic hypoaldosteronism. Endocrinology 1992;131:187-94
35. Raff H, Findling JW. Aldosterone control in critically ill patients: ACTH, metoclopramide, and atrial natriuretic peptide. Crit Care Med 1990;18:915-20
36. Moro N, Katayama Y, Kojima J, Mori T, Kawamata T. Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage. Stroke 2003;34:2807-11
37. Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1999;91:947-52
38. Katayama Y, Haraoka J, Hirabayashi H, Kawamata T, Kawamoto K, Kitahara T, Kojima J, Kuroiwa T, Mori T, Moro N, Nagata I, Ogawa A, Ohno K, Seiki Y, Shiokawa Y, Teramoto A, Tominaga T, Yoshimine T. A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2373-5
39. Hays A, Diringer MN. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology 2006;66:1330-4
40. Naidech AM, Kreiter KT, Janjua N, Ostapkovich ND, Parra A, Commichau C, Fitzsimmons BF, Connolly ES, Mayer SA. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005;112:2851-6
41. McGrath MF, de Bold ML, de Bold AJ. The endocrine function of the heart. Trends Endocrinol Metab 2005;16:469-77
42. Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther 2004;102:223-41
43. Charloux A, Piquard F, Doutreleau S, Brandenberger G, Geny B. Mechanisms of renal hyporesponsiveness to ANP in heart failure. Eur J Clin Invest 2003;33:769-78
44. Glisson SN, Gutzke GE, Pifarre R, Rao TL. Atrial natriuretic peptide responses during anaesthesia in patients with refractory cardiomyopathies. Can J Anaesth 1991;38:572-7